AML/MDS Drug Sensitization by in Vivo Chemotherapy Administration

Clinical trial NCT04263181 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04263181
Sponsor: Washington University School of Medicine
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Acute Myeloid Leukemia Myelodysplastic Syndromes

Start date: 2020-01-29
Primary completion: 2027-01-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.